Eli Lilly won’t lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an AI-powered scheduling assistant.

Health insurers, employers and pharmacy benefit managers may be insulated from the immediate effects of drug tariffs, but ...